Skip to main content
. 2013 Mar 20;8(3):e58672. doi: 10.1371/journal.pone.0058672

Figure 5. HDACi-induced EMT phenotype.

Figure 5

Schematic drawing of the proposed mechanism by which chromatin acetylation influences head and neck tumor behavior. Tumors with hypoacetylated chromatin (low levels of Ac. H3) accumulate and maintain CSC. Pharmacological induction of chromatin acetylation (HDACi) reduces the CSC population and induces EMT, BMI-1 expression and aggressiveness of tumor cells.